Cigna Corp. (CI) Market Value Rose While Friess Associates LLC Has Boosted Position

February 15, 2018 - By Henry Gaston

Investors sentiment is 0.96 in Q3 2017. Its the same as in 2017Q2. It is without change, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Beacon Advsrs reported 695 shares. Columbus Hill Cap Mngmt LP owns 2.53% invested in Cigna Corporation (NYSE:CI) for 189,845 shares. Ngam Advsrs LP holds 52,852 shares. Bancshares Of Nova Scotia invested 0.05% of its portfolio in Cigna Corporation (NYSE:CI). Amer Investment Incorporated invested in 2,183 shares. Park National Corp Oh holds 0.14% in Cigna Corporation (NYSE:CI) or 13,307 shares. Moreover, Hartford Management has 0.19% invested in Cigna Corporation (NYSE:CI) for 54,814 shares. 79,776 were accumulated by Investec Asset Mngmt North America. Riverhead Cap Mgmt Limited Com invested 0.13% of its portfolio in Cigna Corporation (NYSE:CI). Manchester Lc reported 608 shares stake. Whittier Of Nevada holds 2,595 shares or 0.05% of its portfolio. Adage Capital Partners Group Incorporated Limited Liability Company accumulated 357,563 shares. Product Prns Limited Company has invested 0.84% in Cigna Corporation (NYSE:CI). 947,788 are owned by National Bank & Trust Of Montreal Can. Moreover, Rhenman & Asset has 1.31% invested in Cigna Corporation (NYSE:CI).

Since August 16, 2017, it had 0 buys, and 8 sales for $8.84 million activity. The insider MURABITO JOHN M sold $5.77M. Another trade for 2,236 shares valued at $402,366 was sold by Bacus Lisa R. ZARCONE DONNA F sold $1.29 million worth of stock. 212 shares were sold by ZOLLARS WILLIAM D, worth $43,604 on Wednesday, January 10. Shares for $85,184 were sold by HENNEY JANE E MD on Friday, January 12.

Friess Associates Llc increased its stake in Cigna Corp. (CI) by 23.65% based on its latest 2017Q3 regulatory filing with the SEC. Friess Associates Llc bought 19,000 shares as the company’s stock rose 11.09% with the market. The institutional investor held 99,324 shares of the medical specialities company at the end of 2017Q3, valued at $18.57 million, up from 80,324 at the end of the previous reported quarter. Friess Associates Llc who had been investing in Cigna Corp. for a number of months, seems to be bullish on the $46.72 billion market cap company. The stock decreased 2.08% or $4.07 during the last trading session, reaching $191.48. About 1.20 million shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since February 15, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Another recent and important Cigna Corporation (NYSE:CI) news was published by Businesswire.com which published an article titled: “Cigna Increases Minimum Wage to $16 an Hour and Further Accelerates …” on January 31, 2018.

Cigna Corporation (NYSE:CI) Ratings Coverage

Among 20 analysts covering CIGNA (NYSE:CI), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. CIGNA had 59 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of CI in report on Sunday, July 23 with “Buy” rating. Citigroup maintained Cigna Corporation (NYSE:CI) rating on Monday, August 7. Citigroup has “Buy” rating and $198 target. The company was maintained on Tuesday, October 10 by Jefferies. UBS maintained the shares of CI in report on Monday, June 5 with “Buy” rating. RBC Capital Markets maintained Cigna Corporation (NYSE:CI) on Tuesday, August 18 with “Sector Perform” rating. The stock has “Buy” rating by Deutsche Bank on Thursday, July 13. On Tuesday, June 28 the stock rating was initiated by Stifel Nicolaus with “Buy”. The firm earned “Buy” rating on Friday, January 8 by Jefferies. The firm earned “Overweight” rating on Thursday, August 17 by Morgan Stanley. Barclays Capital maintained it with “Equal-Weight” rating and $168 target in Wednesday, January 6 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.